Amundi Purchases 272,444 Shares of Danaher Corporation $DHR

Key Points

• Amundi increased its Danaher stake by 10.4% in the second quarter, purchasing 272,444 shares and bringing its holdings to 2.88 million shares worth approximately $549.3 million.
• Danaher beat quarterly expectations, reporting $1.94 in EPS versus $1.85 expected and $6.26 billion in revenue, up 5.5% year over year.
• Analysts maintain a favorable outlook, with a consensus “Moderate Buy” rating and a $228.91 target price compared with the stock’s reported $207.46 price.

Amundi grew its position in Danaher Corporation (NYSE:DHR - Free Report) by 10.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,883,536 shares of the conglomerate's stock after purchasing an additional 272,444 shares during the period. Amundi owned about 0.41% of Danaher worth $549,256,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. California State Teachers Retirement System grew its position in shares of Danaher by 18,856.0% during the 2nd quarter. California State Teachers Retirement System now owns 184,571,691 shares of the conglomerate's stock valued at $35,157,216,000 after acquiring an additional 183,598,005 shares during the period. BlackRock Inc. bought a new stake in shares of Danaher in the 2nd quarter worth approximately $10,492,520,000. Norges Bank purchased a new position in Danaher in the fourth quarter valued at approximately $2,177,106,000. Jupiter Topco LLC purchased a new position in Danaher in the second quarter valued at approximately $1,456,317,000. Finally, Generation Investment Management LLP bought a new position in Danaher during the second quarter valued at $1,287,949,000. 79.05% of the stock is owned by institutional investors.

Danaher Stock Performance

NYSE:DHR opened at $207.46 on Monday. The stock has a market cap of $145.84 billion, a P/E ratio of 36.85, a PEG ratio of 2.59 and a beta of 0.78. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The business's 50-day moving average price is $201.74 and its two-hundred day moving average price is $192.14. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping the consensus estimate of $1.85 by $0.09. The company had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.Danaher's revenue was up 5.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.77 earnings per share. As a group, equities analysts predict that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on DHR. Deutsche Bank Aktiengesellschaft reissued a "buy" rating and issued a $240.00 target price on shares of Danaher in a research report on Wednesday, July 22nd. Citigroup started coverage on Danaher in a research report on Tuesday, May 26th. They set a "buy" rating and a $230.00 price target on the stock. DZ Bank began coverage on Danaher in a report on Wednesday, June 3rd. They issued a "buy" rating and a $210.00 price objective for the company. Wolfe Research cut Danaher from an "outperform" rating to a "peer perform" rating in a research note on Monday, June 1st. Finally, HSBC dropped their price objective on shares of Danaher from $270.00 to $230.00 and set a "buy" rating on the stock in a report on Wednesday, June 3rd. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, Danaher has a consensus rating of "Moderate Buy" and a consensus target price of $228.91.

Danaher Profile

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source